Acquired hemophilia A (AH) is an autoimmune disease that leads to potentially severe bleeding. Management relies on rapid and accurate diagnosis, control of bleeding episodes and eradication of the inhibitor by immunosuppression. There is extensive literature about the disease but only few controlled data are available. This paper reviews the current literature on treatment strategies for hemostatic therapy and inhibitor eradication. Potential future developments are discussed. © 2007 International Society on Thrombosis and Haemostasis.
CITATION STYLE
Collins, P. W. (2007, May). Treatment of acquired hemophilia A. Journal of Thrombosis and Haemostasis. https://doi.org/10.1111/j.1538-7836.2007.02433.x
Mendeley helps you to discover research relevant for your work.